Biocryst Pharmaceuticals (BCRX) Exchange Rate Effect (2021 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Exchange Rate Effect of -$72000.0 for Q1 2026, little changed on a QoQ basis from -$72000.0 in Q4 2025, and down 115.96% year-over-year from $451000.0 in Q1 2025.
Biocryst Pharmaceuticals (BCRX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Biocryst Pharmaceuticals' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$72000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 115.96% year-over-year to -$72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $747000.0 (up 615.17% YoY) and the FY2025 annual result came in at $1.3 million, up 235.68% from the prior year.
- Exchange Rate Effect was -$72000.0 for Q1 2026 at Biocryst Pharmaceuticals, roughly flat from -$72000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q2 2025 and bottomed at -$1.3 million in Q4 2024.
- A 5-year average of $70000.0 and a median of -$14000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 16450.0% — and 2024, when it plunged 349.81%.
- Biocryst Pharmaceuticals' Exchange Rate Effect stood at $331000.0 in 2022, then jumped by 57.7% to $522000.0 in 2023, then tumbled by 349.81% to -$1.3 million in 2024, then jumped by 94.48% to -$72000.0 in 2025, then changed by 0.0% to -$72000.0 in 2026.
- Business Quant data shows BCRX's Exchange Rate Effect at -$72000.0 in Q1 2026, -$72000.0 in Q4 2025, and -$468000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn | -72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72,000.00 |
| Mar 31, 2026 | -72,000.00 |
| Dec 31, 2025 | -72,000.00 |
| Dec 31, 2025 | -72,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Jun 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 451,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | -1.30 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | 851,000.00 |
| Sep 30, 2024 | 851,000.00 |
| Jun 30, 2024 | -143,000.00 |
| Jun 30, 2024 | -143,000.00 |
| Mar 31, 2024 | -340,000.00 |
| Mar 31, 2024 | -340,000.00 |
| Dec 31, 2023 | 522,000.00 |
| Dec 31, 2023 | 522,000.00 |